NCT01545219

Brief Summary

Healthy volunteers will be recruited to a study where they will be given four different treatments over a 28 week period. These treatments include: a prebiotic, a probiotic, a synbiotic (prebiotic + probiotic) and a placebo. Faecal samples, blood and saliva will be collected and analysed for changes in faecal microbial populations and selected immune responses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 29, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2012

Completed
Last Updated

March 7, 2012

Status Verified

March 1, 2012

Enrollment Period

1 year

First QC Date

February 29, 2012

Last Update Submit

March 6, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes to the gut microbiota

    Changes in faecal bacterial populations will be assessed through the use of FISH with molecular probes targeting 16S rRNA genes. Genotypic probes targeting the predominant components of the gut microflora (Bacteroides, Bifidobacterium, Clostridium, Lactobacillus, Eubacterium, Atopobacterium, Streptococcus, sulphate reducing bacteria and enterobacteria) and total bacteria will be tagged with fluorescent markers such that quantifiable changes may be determined. Concentrations of short chain fatty acids (SCFA) will be quantified using gas chromatography (GC).

    7 months

Secondary Outcomes (1)

  • Bowel function, immune function and plasma lipids

    7 months

Study Arms (4)

Prebiotic

EXPERIMENTAL
Dietary Supplement: Prebiotic

Probiotic

EXPERIMENTAL
Dietary Supplement: Bi-07

Synbiotic

EXPERIMENTAL
Dietary Supplement: Synbiotic

Placebo

PLACEBO COMPARATOR
Dietary Supplement: Placebo

Interventions

PrebioticDIETARY_SUPPLEMENT

8g/day xylo-oligosaccharide

Prebiotic
Bi-07DIETARY_SUPPLEMENT

10\^9 CFU B. lactis / day

Probiotic
SynbioticDIETARY_SUPPLEMENT

8g/day xylo-oligosaccharide + 10\^9 CFU Bi-07

Synbiotic
PlaceboDIETARY_SUPPLEMENT

8g/day maltodextrin

Placebo

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • signed consent form
  • age 25-65 years
  • body mass index 20-30 inclusive
  • good general health as determined by medical questionnaires

You may not qualify if:

  • Evidence of physical or mental disease or planned major surgery, which might limit participation in or completion of the study
  • History of drug abuse, including alcohol
  • Severe allergy or a history of severe abnormal drug reaction
  • Participation in experimental drug trial within four weeks prior to study
  • Participation in prebiotics or laxative trial within the previous three months
  • Use of antibiotics within the previous six months
  • Chronic constipation, diarrhoea or other chronic gastro-intestinal complaint
  • Intake of other prebiotics or probiotics, drugs active on gastrointestinal motility, or a laxative of any class for four weeks prior to study
  • Use of prescribed medication
  • Regular use of aspirin or other anti-inflammatory drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Reading

Reading, Berkshire, RG6 6AP, United Kingdom

Location

MeSH Terms

Interventions

PrebioticsSynbiotics

Intervention Hierarchy (Ancestors)

Dietary FiberDietary CarbohydratesCarbohydratesPolysaccharides, BacterialPolysaccharidesFoodDiet, Food, and NutritionPhysiological PhenomenaDietary SupplementsFood and BeveragesProbiotics

Study Officials

  • Glenn R Gibson, BSc, PhD

    University of Reading

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Post doctoral research fellow

Study Record Dates

First Submitted

February 29, 2012

First Posted

March 6, 2012

Study Start

September 1, 2008

Primary Completion

September 1, 2009

Study Completion

January 1, 2010

Last Updated

March 7, 2012

Record last verified: 2012-03

Locations